Extended and continuous infusions with beta-lactam antibiotics have been suggested as a means of pharmacokinetic and pharmacodynamic optimisation of antimicrobial therapy. Vancomycin is also frequently administered in continuous infusion, although more for practical reasons. A survey was undertaken to investigate the recommendations by the local antibiotic management teams (AMTs) in Belgian acute hospitals concerning the administration (intermittent, extended or continuous infusion) and therapeutic drug monitoring of four beta-lactam antibiotics (ceftazidime, cefepime, piperacillin-tazobactam, meropenem) and vancomycin for adult patients with a normal kidney function. A structured questionnaire survey comprising three domains was developed and approved by the members of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). The questionnaire was sent by e-mail to the official AMT correspondents of 105 Belgian hospitals, followed by two reminders. The response rate was 32 %, with 94 %, 59 %, 100 %, 100 % and 100 % of the participating Belgian hospitals using ceftazidime, cefepime, piperacillin-tazobactam, meropenem and vancomycin, respectively. Comparing intensive care unit (ICU) with non-ICU wards showed a higher implementation of extended or continuous infusions for ceftazidime (81 % vs. 41 %), cefepime (35 % vs. 10 %), piperacillin-tazobactam (38 % vs. 12 %), meropenem (68 % vs. 35 %) and vancomycin (79 % vs. 44 %) on the ICU wards. A majority of the hospitals recommended a loading dose prior to the first dose. For vancomycin, the loading dose and the trough target concentration were too low based on the current literature. This survey shows that extended and continuous infusions with beta-lactams and vancomycin are widely implemented in Belgian hospitals.
Article de périodique (Journal article) – Article de recherche
Access type
Accès restreint
Publication date
2013
Language
Anglais
Journal information
"European Journal of Clinical Microbiology & Infectious Diseases : an international journal on pathogenesis, diagnosis, epidemiology, therapy, and prevention of infectious diseases" - Vol. 32, no.6, p. 763-768 (2013)
Craig William A, Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid, 10.1016/s0891-5520(03)00065-5
Roberts Jason A., Webb Steven, Paterson David, Ho Kwok M., Lipman Jeffrey, A systematic review on clinical benefits of continuous administration of β-lactam antibiotics* : , 10.1097/ccm.0b013e3181a0054d
Cataldo M. A., Tacconelli E., Grilli E., Pea F., Petrosillo N., Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis, 10.1093/jac/dkr442
Wysocki M., Delatour F., Faurisson F., Rauss A., Pean Y., Misset B., Thomas F., Timsit J.-F., Similowski T., Mentec H., Mier L., Dreyfuss D., Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized Study, 10.1128/aac.45.9.2460-2467.2001
Van Gastel Evelyne, Costers Michiel, Peetermans Willy E., Struelens Marc J., Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey, 10.1093/jac/dkp470
Claus B., Buyle F., Robays H., Vogelaers D., Importance of Infusion Volume and Pump Characteristics in Extended Administration of -Lactam Antibiotics, 10.1128/aac.00754-10
Geggie D., Moore D., Peripheral line dead space: an unrecognised phenomenon?, 10.1136/emj.2007.046250
Sanford JP, Gilbert D, Chambers H, Eliopoulos GM, Moellering R, Saag M (2010) The Sanford guide to antimicrobial therapy, 2010–2011, 22nd edn. Belgian/Luxembourg version. Belgian/Luxembourg Working Party on Antimicrobial Therapy. ISBN 978-1-930808-63-3
Federal Agency for Medicines and Health Products (FAMHP) Summary of product characteristics (SPC) for vancocin. Available online at: http://bijsluiters.fagg-afmps.be/ . Accessed 1 Oct 2012
Federal Agency for Medicines and Health Products (FAMHP) Summary of product characteristics (SPC) for glazidim. Available online at: http://bijsluiters.fagg-afmps.be/ . Accessed 1 Oct 2012
Van Herendael Bruno, Jeurissen Axel, Tulkens Paul M, Vlieghe Erika, Verbrugghe Walter, Jorens Philippe G, Ieven Margareta, Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?, 10.1186/2110-5820-2-22
Roberts Jason A., Kirkpatrick Carl M.J., Roberts Michael S., Dalley Andrew J., Lipman Jeffrey, First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis, 10.1016/j.ijantimicag.2009.10.008
Ocampos-Martinez Eva, Penaccini Laura, Scolletta Sabino, Abdelhadii Ali, Devigili Alessandro, Cianferoni Silvia, de Backer Daniel, Jacobs Frédérique, Cotton Frédéric, Vincent Jean-Louis, Taccone Fabio Silvio, Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients, 10.1016/j.ijantimicag.2011.12.008
Truong J., Levkovich B. J., Padiglione A. A., Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels : Simple approach to improving vancomycin dosing, 10.1111/j.1445-5994.2011.02459.x
Li Janice, Udy Andrew A., Kirkpatrick Carl M.J., Lipman Jeffrey, Roberts Jason A., Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study, 10.1016/j.ijantimicag.2011.08.017
Rybak M., Lomaestro B., Rotschafer J. C., Moellering R., Craig W., Billeter M., Dalovisio J. R., Levine D. P., Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists, 10.2146/ajhp080434
Taccone Fabio Silvio, Laterre Pierre-François, Dugernier Thierry, Spapen Herbert, Delattre Isabelle, Witebolle Xavier, De Backer Daniel, Layeux Brice, Wallemacq Pierre, Vincent Jean-Louis, Jacobs Frédérique, Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock, 10.1186/cc9091
Roberts Jason A., Ulldemolins Marta, Roberts Michael S., McWhinney Brett, Ungerer Jacobus, Paterson David L., Lipman Jeffrey, Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept, 10.1016/j.ijantimicag.2010.06.008
Udy Andrew A., Varghese Julie M., Altukroni Mahdi, Briscoe Scott, McWhinney Brett C., Ungerer Jacobus P., Lipman Jeffrey, Roberts Jason A., Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients, 10.1378/chest.11-1671
Pea F., Furlanut M., Negri C., Pavan F., Crapis M., Cristini F., Viale P., Prospectively Validated Dosing Nomograms for Maximizing the Pharmacodynamics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients, 10.1128/aac.01149-08
Carricajo A., Forgeot A., Morel J., Auboyer C., Zeni F., Aubert G., Ajustement de la posologie de la vancomycine administrée en perfusion continue chez des patients de réanimation, 10.1016/j.annfar.2009.12.002
Spapen Herbert D, Janssen van Doorn Karin, Diltoer Marc, Verbrugghe Walter, Jacobs Rita, Dobbeleir Nadia, Honoré Patrick M, Jorens Philippe G, Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients, 10.1186/2110-5820-1-26
Ingram P. R., Lye D. C., Tambyah P. A., Goh W. P., Tam V. H., Fisher D. A., Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy, 10.1093/jac/dkn080
Gupta A, Biyani M, Khaira A (2011) Vancomycin nephrotoxicity: myths and facts. Neth J Med 69:379–383
Baririan N., Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units, 10.1093/jac/dkg134
KUTI J, Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis*1, 10.1016/s0149-2918(04)90051-3
Berthoin K., Le Duff C. S., Marchand-Brynaert J., Carryn S., Tulkens P. M., Stability of meropenem and doripenem solutions for administration by continuous infusion, 10.1093/jac/dkq044
Bibliographic reference
Buyle, Franky M ; Decruyenaere, Johan ; De Waele, Jan ; Tulkens, Paul M. ; Van Audenrode, Thijs ; et. al. A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals. In: European Journal of Clinical Microbiology & Infectious Diseases : an international journal on pathogenesis, diagnosis, epidemiology, therapy, and prevention of infectious diseases, Vol. 32, no.6, p. 763-768 (2013)
